Troy, N.Y. — Two attorneys who represent and advise start-up companies will share their business insights on Wednesday, Oct. 9, from 5:30 to 6:30 p.m. in room 5114 of the Pittsburgh Building on Rensselaer’s campus.

The event is the first in the 2002-2003 Biotechnology Management and Entrepreneurship Seminar Series hosted by Rensselaer’s Lally School of Management and Technology and the Severino Center for Technological Entrepreneurship, and is co-marketed by the Center for Economic Growth and the New York Biotechnology Association. The series will address a wide range of issues facing biotechnology start-ups.

The event is free and open to the public.

Ellen Corenswet and Daryn Grossman, lawyers with Brobeck, Phleger & Harrison LLP from New York, will deliver a talk on intellectual property titled “Patents and Business Models in Biotechnology: How to start and grow a company with an idea-A view from the trenches.”

“These speakers have hands-on experience in structuring a wide variety of business models and patent management strategies in the biotechnology industry,” said Shreefal Mehta, series organizer and a research assistant professor of biotechnology management in the Lally School. “They will give inspiring and creative ideas to students through their experience, hands-on wisdom, and insights.”

All seminars will take place in the Pittsburgh Building, room 5114, from 5:30 to 6:30 p.m. unless otherwise noted. They begin and end with a half-hour reception for speakers and attendees at 5 p.m. and 6:30 p.m.

The schedule for the remaining dates in the series is as follows:

* Nov. 6, Heffner Alumni House, James Mullen ’80, president and CEO of Biogen Inc., “The Forest and the Trees: My perspectives on the biotechnology industry.”

* Nov. 20, Rahul Dhanda, of Interleukin Genetics and author of Guiding Icarus, “Bioethics for entrepreneurs, engineers, and executives.”

* Feb. 5. A Capital Region showcase of biotechnology companies including Evident Technologies, Avax Technologies, Taconic Biotech, and Applied Biophysics.

* Feb. 26, Randall Rupp, senior vice president of manufacturing and process science of Regeneron, “Regeneron: A biotech company in progress.”

* March 26, Brendan and Brian McKernan, vice president of manufacturing and operations and CEO, respectively, of Agencourt Bioscience Corporation, “Growing a company in the biotech industry: A Lally Alumnus’ Success Story.”

For more information, e-mail Shreefal Mehta at mehtas@rpi.edu or check out the series’ Web site at http://scte.mgmt.rpi.edu/bioentrepseries/index.html.

About the Severino Center
Established in 1988, the Paul J. ’69 and Kathleen M. Severino Center for Technological Entrepreneurship helps budding and successful entrepreneurs make the transition from academia to the “real world” through outreach programs, education and research. It is centered in Rensselaer’s Kenneth T. and Thelma P. Lally School of Management and Technology, and lies at the core of the school’s mission to educate future business leaders who will guide their organizations in the conversion of technical ideas into new businesses, products, processes, and systems.

Contact: Caroline Jenkins
Phone: (518) 276-6531
E-mail: N/A